Sangam Health Care Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/02/2026 ,inter alia, to consider and approve 1. Appointment ....
Awaiting price reaction for this filing.
Sangam Health Care Products Ltd has informed BSE that its Board of Directors will meet on 24 February 2026 at the registered office. The main agenda item is to consider and approve the appointment of a Chief Financial Officer (CFO) for the company. The notice also includes a standard 'any other business with the permission of the Chair' item. The intimation is signed by Managing Director D. Bhagat Reddy and filed under SEBI Listing Regulations. The document does not disclose the name of the proposed CFO or any reason such as a prior resignation.
Neutral to mildly positive — appointing a CFO is a routine governance event, but the lack of disclosed context (e.g., replacement due to resignation) leaves some uncertainty. Shareholders should watch for the outcome on 24 Feb to confirm whether this is a normal succession or a reaction to a prior vacancy.